Name: See MENARINI Group’s activity on LinkedIn
Uploaded: 2024-12-12T19:10:26.638Z
Duration: 10 s
Channel: MENARINI Group
Description: Menarini Group and MEDSIR present the Phase III study ADELA, a potential new therapeutic strategy for advanced breast cancer. Read today’s press release here: https://bit.ly/3OSZdA0

MENARINI Group reposted this

Menarini Stemline

34,627 followers

1mo

Menarini Group and MEDSIR present the Phase III study ADELA, a potential new therapeutic strategy for advanced breast cancer. Read today’s press release here: https://bit.ly/3OSZdA0

5 Comments

Lucas Grein

1mo

Very interesting, Menarini Stemline, breast cancer and her2 treatment really need an upgrade as the current market is saturated.

Mithra Bindhu

Enabling #Pharma and #Biotech clients with their research questions

1mo

Congrats! To the Menarini Stemline team

Natalia Vega Tojo

Key Account Manager en Stemline-Menarini oncohematología

1mo

¡Enhorabuena!

MENARINI Group’s Post

Explore topics